Preserving the Invisible. Powering the Future.
Welcome to the Epolleo Curated Library System
The Epolleo Curated Library serves as a global microbial life archive designed to protect biodiversity conservation and foster innovation within the scientific research platform.
Innovative Science and Technology Solutions
Executive Summary
The result is a scientific research platform that not only preserves the unseen biodiversity of Earth’s microbial ecosystems but also transforms it into accessible, actionable knowledge. With the potential to save millions—if not billions—of dollars in redundant research costs and significantly reduce production timelines, Epolleo represents a paradigm shift in how science, society, and industry interact with microbial life. This innovative microbial life archive enables community-driven collection of microbial samples across diverse geographic regions and ecosystems. Contributors—from academic institutions and conservation groups to classrooms and rural communities—gather samples using standardized protocols that ensure consistency in metadata, geographic tagging, and environmental context. These samples, when collected at scale, provide a representative portrait of the microbial diversity essential for biodiversity conservation in local ecosystems and endangered habitats. Once submitted to Epolleo, samples enter a centralized processing pipeline managed by Epolleo Inc.’s scientific team. This pipeline includes microbial isolation, cultivation under varied media and environmental conditions, genomic sequencing, and chromatographic screening of metabolites and exudates. These techniques provide a functional fingerprint of each microbe’s biochemical potential—capturing critical traits such as antimicrobial activity, soil stabilization capacity, bioplastic degradation, and symbiotic plant support. Processed samples are cataloged and made fully searchable through Epolleo’s online platform, offering researchers, universities, startups, and public-sector agencies a streamlined path to microbial innovation. Unlike traditional pipelines that require years of up-front lab work and resource allocation, Epolleo delivers curated, traceable, and partially screened samples—greatly reducing time to market and accelerating solution development in fields ranging from agriculture and human health to climate resilience and industrial materials. To extend the scientific utility of each sample, Epolleo also retains a fraction of both live cultures and growth media. These are made available to vetted university laboratories worldwide, where distributed screenings further explore the microbes’ functionality under unique, independent conditions. All new data from these secondary screenings—referred to as additionality—are reintegrated into Epolleo’s global database, enriching the system’s predictive and exploratory power. This dual-loop model—collection and central screening, followed by global distributed research—creates a dynamic, nonlinear innovation engine. By making deeply contextual microbial data openly available and easily integrable, Epolleo reduces duplication, fosters collaboration, and opens up low-cost, high-impact innovation pathways for institutions and industries that might otherwise lack the infrastructure to launch full-scale microbial R&D. The result is a platform that not only preserves the unseen biodiversity of Earth’s microbial ecosystems but also transforms it into accessible, actionable knowledge. With the potential to save millions—if not billions—of dollars in redundant research costs and significantly reduce production, as well as cut development time, Epolleo represents a paradigm shift in how science, society, and industry interact with microbial life. This is not just a library; it is a launchpad for the next century of biological innovation.
Join Us In Expanding the Library
Discover how BioDiversity Platform can help your business with our range of services, including scientific research, technology development, and consulting.
Methods
1. Field Collection Protocols
Participants receive an Epolleo Collection Kit designed to support biodiversity conservation efforts, which includes: Sterile soil coring tools for collecting sub-surface samples without contamination, a GPS-enabled logging app or data card to accurately capture latitude, longitude, and elevation, an environmental data sheet to document vegetation cover, weather conditions, and land use, pH and moisture test strips to provide chemical context, and pre-labeled sterile containers with tamper-proof barcodes and sample ID slips. Collectors are trained through online modules or in-person workshops, adhering to standardized guidelines for collection depth and location (e.g., 5–10 cm for rhizosphere soil), ensuring replicates per site for representativeness, capturing site photography that includes wide-angle and close-up shots, and ensuring immediate cooling and secure packaging to maintain biological integrity during transit for a comprehensive microbial life archive that supports scientific research platforms.
2. Sample Documentation and Submission
All participants upload documentation through the Epolleo Submission Portal, contributing to the biodiversity conservation efforts. Here, they:
Input detailed metadata including GPS coordinates, sample type (soil, leaf surface, water), ecosystem category, and human impact markers to enhance the microbial life archive.
Upload photographs and optional field notes.
Declare the collection team and project affiliation.
Verify consent to Epolleo's IP and data-sharing policies, which support the scientific research platform.
Submissions are reviewed by automated scripts and human screeners for:
Completeness of metadata.
Consistency of environmental context.
Barcoded label match.
Only validated samples move forward.
3. Centralized Sample Processing
4. Metabolite and Exudate Screening
Epolleo’s central facility functions as a vital scientific research platform, receiving, logging, and storing incoming samples in a climate-controlled environment, which supports biodiversity conservation efforts.
Each sample is:
- Logged with a digital accession number and metadata confirmation.
- Aliquoted into multiple growth media: R2A, PDA, LB, nutrient agar, and other custom formulations tailored for a microbial life archive.
- Incubated under varied conditions: aerobic vs. anaerobic; temperature (4°C, 25°C, 37°C); pH variants.
- Observed daily for colony morphology, pigmentation, and rate of growth.
For genotyping:
- DNA is extracted using validated microbial kits.
- Sequencing includes 16S rRNA for bacteria, ITS for fungi, or shotgun metagenomics as appropriate.
- Sequencing results are analyzed using QIIME2 and annotated against global databases (SILVA, NCBI).
4. Metabolite and Exudate Screening
6. Distributed Screening and Additionality Analysis
4. Metabolite and Exudate Screening
Each isolate undergoes metabolomic analysis under all growth scenarios, contributing to our efforts in biodiversity conservation. This process includes: Chromatographic screening (HPLC, GC-MS, LC-MS) for detecting organic acids, secondary metabolites, pigments, and VOCs, forming part of our microbial life archive. Metabolite mapping is compared against standard libraries (e.g., KEGG, PubChem) as we aim to enhance our scientific research platform. Additionally, activity-guided fractionation tests for antifungal, antibacterial, enzymatic, or symbiotic function. Screening outputs are digitized into a unique biochemical signature per sample.
5. Cataloging and Research Access
6. Distributed Screening and Additionality Analysis
6. Distributed Screening and Additionality Analysis
Validated samples are entered into the Epolleo Curated Library, which serves as a vital scientific research platform for biodiversity conservation. Each sample is assigned a Diversity Credit that includes: traceable sample ID, geographic origin, and ecosystem classification; growth data and observable traits; sequencing profiles and metabolomic maps; and access conditions (e.g., open access, restricted, research license).
The searchable microbial life archive features: filters for ecosystem, organism type, function, growth rate, location, and user origin; exportable datasets with standard citations; and API integration for institutional research dashboards.
6. Distributed Screening and Additionality Analysis
6. Distributed Screening and Additionality Analysis
6. Distributed Screening and Additionality Analysis
A fraction of each sample and its growth media is:
Cryopreserved and/or lyophilized.
Packaged with detailed lab instructions.
Sent to accredited university and lab partners globally, contributing to a microbial life archive that supports biodiversity conservation.
These labs conduct additional functional assays including:
Biocontrol potential, e.g., inhibition zone assays.
Plant-growth promotion, e.g., auxin quantification.
Enzymatic activity, e.g., cellulase or protease assays.
Antimicrobial resistance testing using ESKAPE pathogens.
Each external screening reports:
Method used and controls.
Observed impact.
And between 1–100 reflecting strength, novelty, scalability, and application potential.
Full metadata and images.
These results are reviewed, verified, and integrated back into the Epolleo database, enhancing the scientific research platform.
7. Feedback Loop and Continuous Data Enrichment
8. Innovation Pipeline and Time-to-Market Advantage
8. Innovation Pipeline and Time-to-Market Advantage
New findings are continuously appended to the original sample’s record within our scientific research platform, enabling:
- Cross-referencing with previous data.
- Building longitudinal insights (e.g., multi-season performance).
- Flagging of “high-impact” microbes for biodiversity conservation efforts and targeted campaign strategies.
Contributors and screening partners receive credit and may be invited to co-author publications or pursue licensing opportunities with industry partners under Epolleo’s ethical sharing model, further enhancing our microbial life archive.
8. Innovation Pipeline and Time-to-Market Advantage
8. Innovation Pipeline and Time-to-Market Advantage
8. Innovation Pipeline and Time-to-Market Advantage
Epolleo reduces the development burden for public and private innovators by:
Eliminating discovery-phase redundancies—samples from our microbial life archive are pre-screened, validated, and profiled.
Providing fully contextual metadata to enable geographic or ecological filtering for biodiversity conservation.
Offering licensing pathways that match organisms to commercial interests.
This allows startups, R&D groups, and institutional labs to:
Save months or years of exploratory lab work.
Avoid repeating failed trials.
Focus on targeted testing and development using our scientific research platform.
Estimated impact includes:
Cost savings in the millions of dollars per development cycle.
Time-to-market reduction of 30–70%.
Increased success rate of biologically-derived innovations.
Discussion
8. Innovation Pipeline and Time-to-Market Advantage
Discussion
The Epolleo Biodiversity Platform employs a multi-tiered methodology designed to systematically collect, process, and analyze microbial samples through collaboration with researchers, environmentalists, educators, and citizen scientists. The aim is to create a comprehensive microbial life archive that fosters innovation and supports biodiversity conservation on a global scale.
Through these approaches, Epolleo establishes a living, scalable infrastructure for documenting, preserving, and unlocking the world's microbial potential—while equitably engaging the global community in this scientific research platform focused on biodiversity.